Digestive Activity Articles & Analysis: Older
4 news found
LB1148 is an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. ...
About LB1148 LB1148 is a novel oral liquid formulation of the well-characterized digestive enzyme inhibitor, tranexamic acid (“TXA”), with potential to both reduce abdominal adhesions and help restore bowel function following surgery. ...
Please click the link below to register for the webcast: https://us06web.zoom.us/webinar/register/WN_ThNZHlT4Q9mBMGrMlxabkg About LB1148 LB1148 is an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. Evidence suggests that the release of ...
Please click the link below to register for the webcast: https://us06web.zoom.us/webinar/register/WN_ThNZHlT4Q9mBMGrMlxabkg About LB1148 LB1148 is an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. Evidence suggests that the release of ...